Herantis Pharma Plc's shares subscribed with option rights
Herantis Pharma PlcCompany release, 18 June 2020 at 9:30 AM Eastern European Summer Time An aggregate number of 39,600 new shares of Herantis Pharma Plc ("Herantis") have been subscribed for with option rights under the option programs 2010, 2014 and 2016 I. The new shares have been registered with the trade register maintained by the Finnish Patent and Registration Office today. The new shares will confer shareholder rights in Herantis after they have been issued in the book-entry system, on or about 19 June 2020. Trading with the new shares is expected to commence on the Nasdaq